|
|||
|
迈劲药业集团有限公司简介 |
|||
公司简介 迈劲制药有限公司是一家外商独资制药企业，生产工厂设在天津经济技术开发区（天津迈劲制药有限公司）。一期投资总额为 600 万美元，厂房总占地面积为 45711.11 平方米，一期厂房建筑面积为 5000 平方米，即将于 2006 年初通过国家 GMP 认证。 其下属的北京迈劲医药科技有限公司是北京市科技委认证的科研机构，高新技术企业，有强大的技术与眼法能力，生产工艺和技术水平居于国内外领先地位。 迈劲制药与国内多家知名企业如：扬子江药业集团，哈药集团，丰原集团，双褐药业等多家企业都有深入的合作，并与日本，韩国，以色列的制药企业建立了广泛的联系。 新型化学原料药，药物中间体和定制化学产品的开发，生产的服务是迈劲制药发展的重点。发展新型抗生素原料药，与国外合作开发创新药物的合作，进行委托生产和委托开发是迈劲未来的发展方向。迈劲制药希望在上述领域与国内外药品研发，生产和销售企业开展全防卫的共赢合作。 主营业务：新型化学原料药，药物中间体，定制化学产品的开发和生产服务。
Company Introduction Mediking Pharmaceutical Group ( Mediking Group) is a privately owned company, which is specified in pharmaceutical area and is focused on R&D, custom synthesis, contract manufacturing and producing of APIs and intermediates. Mediking Group was registered in Hong Kong in 1999 and has three subsidiaries including Beijing Mediking Pharmaceutical Co., Ltd., ( Beijing Mediking ) Tianjin Mediking Pharmaceutical Co., Ltd. ( Tianjin Mediking ) and Medichem International Holdings Ltd. (Medichem) Beijing Mediking Pharmaceutical Co., Ltd., registered in Beijing Economic and Technology Development Area, is a famous Chinese R&D company. Beijing Mediking is recognized as a Hi-Tech company by the Beijing Municipal Science & Technology Commission (BMSTC) and is supported by Beijing Medium and small business Financial Project. Being a role model among the R&D companies in China, the company was being visited by the leaders of the Beijing People's Congress and BMSTC for several times. Now the company has 36 R&D scientists and technicians, assuring Beijing Mediking's leading position in its field. Beijing Mediking also cooperates with many national –degree academic associates such as Chinese Academy of Science, Beijing University , Lanzhou University , Chinese Pharmaceutical University and Shenyang Pharmaceutical University etc. Our long-term customers are all well-known local pharmaceutical companies in China including the top-two companies Yangtze River Pharmacy Group and Harbin Pharmaceutical Group. Tianjin Mediking Pharmaceutical Co., Ltd is located in Tianjin Economical Development Area (TEDA) and is focused on contract manufacturing and producing of new APIs and intermediates. Our major products series are new antibiotics, Cardiovascular System and Neuro-muscular System drugs. Our factory is built according American FDA's cGMP's standard. The first phase of 5000m 2 production line has been in used since Aug.2005 and is preparing for FDA's inspection. In order to maintain our leading position in R&D, Tianjin Mediking has also cooperated with Chinese Academy of Science in setting up a R&D center for chiral drugs. Medichem International Holdings Ltd is registered in Hong Kong and is focused on international trading of new APIs and intermediates and technology transfers. Medichem has joined hands with many foreign pharmaceutical companies and traders from Eastern Asian, India , European, and now is actively exploring American market. Mediking Group devotes itself in its advantageous field: R&D, custom synthesis, contract manufacturing and producing of new APIs and intermediates. Our target is to provide the best service to both domestic and international pharmaceutical enterprises and build mutual benefits business. 中国医药咨询网 www.yy2000.com
地 址 : 北京市昌平区北七家镇宏翔鸿企业孵化基地 102209 Address : Hongxianghong Fuhuaqi base, Beiqijia Town, Changping District, Beijing 102209, P.R.C Tel: 0086-10-8176-9601 Fax: 0086-10-8176-9679 Web Site: http://www.mediking.cn E-mail: wjl@mediking.cn |
|